AdaptHealth Corp. (AHCO) vs Cytek Biosciences, Inc. (CTKB)

A side-by-side comparison of AdaptHealth Corp. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AHCO vs CTKB

growth of $100 · dividends reinvested · last 5y
AHCO -74.3% (-23.8%/yr)CTKB -67.5% (-20.1%/yr)CTKB compounded faster over this window
50100150Start $10020222023202420252026$26$32
AHCO CTKB

AHCO vs CTKB: by the numbers

  • •AHCO is the larger company ($796M vs $724M market cap).
  • •Both run net losses; AHCO's is the smaller (-7.58% vs -38.98% net margin).
  • •CTKB grew revenue faster over the past five years (13.37% vs 11.68% CAGR).

Metrics side by side

Valuation

MetricAHCOCTKB
P/S ratio0.263.50
P/B ratio0.582.25
EV / EBITDA6.65N/A
FCF yield12.28%N/A

Profitability

MetricAHCOCTKB
Gross margin10.37%53.23%
Operating margin-0.31%-21.60%
Net margin-7.58%-38.98%
ROE-16.56%-25.03%
ROIC-0.26%-12.00%

Growth (annualized)

MetricAHCOCTKB
Revenue CAGR (5Y)11.68%13.37%
FCF CAGR (5Y)7.07%N/A
Total return CAGR (5Y)-24.65%-23.16%

Frequently asked

Which has grown faster, AHCO or CTKB?
Over the past five years, CTKB grew revenue faster — AHCO at a 11.68% CAGR versus CTKB at 13.37%.
How have AHCO and CTKB total returns compared?
Over the past 5 years, AHCO delivered -24.65% and CTKB delivered -23.16% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.